It has recently been suggested that diazepam ('Valium') has cardiac anti-arrhythmic properties (Van Loon, I968; Papp, I969) . This drug has been used alone for heavy sedation before electrical conversion of arrhythmias in our department for the past 2 years. We have studied the anti-arrhythmic properties of diazepam in the clinical setting and in experimentally-induced arrhythmias in the dog.
The purpose of this paper is to report our findings.
Clinical study Material and methods Diazepam was given intravenously (5-75 mg.) to i42 patients on I64 different occasions before attempting electrical conversion of an arrhythmia. These arrhythmias were atrial fibrillation (iii instances), atrial flutter (38), supraventricular tachycardia (7), and ventricular tachycardia (8). Diazepam was given to these patients for its sedative and hypnotic effect, and its use allowed direct current (DC) shock therapy to be given without general anaesthesia and tracheal intubation.
Results
The major underlying pathology in our patients was rheumatic heart disease (i I2 cases), ischaemic heart disease (I9 cases), undetermined or 'lone' (5 cases), chronic lung disease (4 cases), and treated thyrotoxicosis (3 cases). The remaining I7 patients suffered from combinations of these diseases and miscel- Direct current shocks were given externally using a Corbin-Farnsworth defibrillator. The electrode paddles measuring 9 cm. in diameter were covered with conductive paste and applied with pressure on either side of the shaved chest at the level of the cardiac apex beat. The sites were marked and used on each occasion.
The DC shock was synchronized with the electrocardiogram to occur i8 milliseconds after the peak of the R wave. To determine the ventricular tachycardia threshold, shocks were given every I0 seconds. The ventricular tachycardia threshold was defined as the energy level at which 3 consecutive DC condensor discharges produced a run of 3 or more consecutive ventricular complexes, with abnormal QRS configuration at a rate exceeding 60 a minute, and occurring within 3 seconds of the shock. The initial shock was given at an energy setting of 40 or 6o watt seconds (w.sec.). If ventricular tachycardia developed (positive response), the energy was reduced to 20, and then I0 w.sec. If it did not occur (negative response), the energy level was increased progressively to 80, I00, 200, 300, and 400 w-sec. In 8 dogs a stable control period of 6o to 95 minutes was established before giving diazepam. The threshold during this period was determined every I5 minutes. Diazepam was given rapidly intravenously as a single dose of 20 mg. Thresholds were then measured after 5 minutes, after a further I0 minutes, and subsequently every i5 minutes for a total of go minutes after giving the drug. In 4 dogs, thresholds were determined at I5-minute intervals for 4 hours without giving diazepam.
In a further experiment, each of 5 different dogs weighing I3-6 to 2I-8 kg. (average I7'3 kg.) were studied twice at weekly intervals. The dose of strophanthidin K ('Strophosid') necessary to produce toxicity (stable ventricular tachycardia) was determined by infusing the drug at a rate of zoo ,ug. a minute for 5 minutes, followed by 50 ,ug. every 5 minutes until supraventricular tachycardia or ventricular ectopic beats occurred. Then 50 ,ug. was given every I0 minutes until ventricular tachycardia occurred (Fig. 3) . In one of the two studies which were performed in random order, the dog was pretreated with diazepam (20 mg.) IS minutes after induction of anaesthesia. After a further I5 minutes, strophanthidin K was infused until toxicity occurred. In both experiments the strophanthidin dose schedules were identical.
Eight dogs were studied to determine the ventricular tachycardia threshold before and after giving diazepam. These dogs maintained a satisfactory acid base balance throughout the experiment and had control thresholds between 40 and 300 w.sec. In one, the threshold did not change after giving diazepam. The remaining 7 dogs showed a rise in threshold after diazepam. The mean threshold before diazepam was 142 w.sec. (SD 871I). After diazepam the mean threshold rose to i87 w.sec. (SD 86-2) . The difference in these values is significant at the 5 per cent level (t = 2 577). In Fig. 4 a typical rise of ventricular tachycardia threshold after the administration of diazepam is illustrated. In Fig. 5 Our clinical experience has been that diazepam has no effect on established atrial fibrillation. Unfortunately we have no details on the incidence of ectopic beats in our patients with atrial fibrillation before and after cardioversion. Diazepam can, therefore, not be compared with other anaesthetic agents in this respect. Our finding that increased atrioventricular block occurred after giving diazepam in 3 out of 38 patients with atrial flutter suggests that diazepam is not quinidine-like in action. Quinidine in the undigitalized patient has long been known to reduce the atrial rate in atrial flutter without significantly reducing atrioventricular conduction, thereby often paradoxically increasing the ventricular rate. A similar effect has also been described after the use of lignocaine, antazoline, and diphenylhydantoin (Dreifus, Rabbino, and Watanabe, I964; Grissom et al., I967; Adamson and Spracklen, I968) .
A decrease in atrioventricular conduction would be expected with a propranolol-like drug. Diazepam, however, did abolish atrial tachycardia in one of our cases. This effect, together with slowing of atrioventricular conduction in atrial flutter, is found with parasympathomimetic agents, like edrophonium chloride (Tensilon) (Moss and Aledort, I966 
